| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 251.91B | 232.98B | 233.41B | 233.87B | 196.58B |
| Gross Profit | 83.74B | 76.18B | 73.52B | 68.19B | 60.08B |
| EBITDA | 43.35B | 43.19B | 39.87B | 36.22B | 31.24B |
| Net Income | 25.31B | 24.27B | 22.09B | 20.22B | 16.77B |
Balance Sheet | |||||
| Total Assets | 352.75B | 333.65B | 324.11B | 293.10B | 273.29B |
| Cash, Cash Equivalents and Short-Term Investments | 84.51B | 99.08B | 94.04B | 85.22B | 74.39B |
| Total Debt | 67.69B | 69.65B | 73.43B | 65.65B | 74.78B |
| Total Liabilities | 160.17B | 155.40B | 158.79B | 148.02B | 145.61B |
| Stockholders Equity | 188.75B | 174.75B | 162.16B | 142.52B | 126.06B |
Cash Flow | |||||
| Free Cash Flow | 2.08B | 18.51B | 9.71B | 25.13B | 8.13B |
| Operating Cash Flow | 17.22B | 25.91B | 25.73B | 34.15B | 24.95B |
| Investing Cash Flow | -19.14B | -8.77B | -20.77B | -10.70B | -17.82B |
| Financing Cash Flow | -12.30B | -15.28B | 3.03B | -12.95B | -5.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥1.02T | 8.70 | 19.60% | 1.94% | 3.42% | 30.95% | |
69 Neutral | ¥228.17B | 8.58 | ― | 2.67% | 8.13% | 7.00% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | ¥158.96B | 9.30 | 14.78% | 2.95% | 16.84% | 22.03% | |
61 Neutral | ¥923.60B | 9.73 | 11.06% | 2.88% | 8.32% | 24.62% | |
58 Neutral | ¥152.98B | 14.03 | 8.95% | 3.39% | 20.87% | 16.79% | |
47 Neutral | ¥40.59B | 31.59 | ― | 3.75% | -4.28% | -60.96% |